MARKET

PETS

PETS

Petmed Express Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.60
+0.83
+4.00%
Closed 16:00 05/25 EDT
OPEN
20.74
PREV CLOSE
20.77
HIGH
22.11
LOW
20.57
VOLUME
471.81K
TURNOVER
--
52 WEEK HIGH
46.67
52 WEEK LOW
19.09
MARKET CAP
453.15M
P/E (TTM)
20.86
1D
5D
1M
3M
1Y
5Y
Short Volatility Alert: PetMed Express
On Friday, shares of PetMed Express (NASDAQ: PETS) experienced volatile short activity. After the activity, the stock price went down -1.19% to $19.95. The overall sentiment for PETS has been Bearish.
Benzinga · 2d ago
Is PetMed Express, Inc. (NASDAQ:PETS) Trading At A 44% Discount?
In this article we are going to estimate the intrinsic value of PetMed Express, Inc. ( NASDAQ:PETS ) by taking the...
Simply Wall St. · 05/12 14:36
PetMed quarterly sales suffer from slow start to flea-and-tick season but subscription business grows
PetMed Express Inc. says its fiscal fourth-quarter sales suffered from a slow start to the flea-and-tick season, but the company expects that part of the business to bounce back as the warm weather sets in. "[A] cooler March in much of the country delayed ...
marketwatch.com · 05/10 16:32
--Morgan Stanley Adjusts PetMed Express' Price Target to $20 from $21, Keeps Underweight Rating
MT Newswires · 05/10 12:17
PetMed (PETS) Q4 Earnings Top Estimates
PetMed (PETS) delivered earnings and revenue surprises of 11.11% and 2.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/09 21:35
BRIEF-PetMeds Express Q4 Earnings Per Share $0.30
reuters.com · 05/09 20:58
PetMed Express declares $0.30 dividend
PetMed Express (NASDAQ:PETS) declares $0.30/share quarterly dividend, in line with previous. Forward yield 5.81% Payable May 27; for shareholders of record May 20; ex-div May 19. See PETS Dividend Scorecard,
Seekingalpha · 05/09 20:01
PetMed Express GAAP EPS of $0.30, revenue of $66M
PetMed Express press release (NASDAQ:PETS): Q4 GAAP EPS of $0.30. Revenue of $66M (-7.9% Y/Y).
Seekingalpha · 05/09 20:01
More
No Data
Learn about the latest financial forecast of PETS. Analyze the recent business situations of Petmed Express Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

33.33%Strong Buy
0.00%Buy
33.33%Hold
33.33%Under-perform
0.00%Sell
Analyst Price Target
The average PETS stock price target is 24.00 with a high estimate of 30.00 and a low estimate of 20.00.
High30.00
Average24.00
Low20.00
Current 21.60
EPS
Actual
Estimate
0.090.180.260.35
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Institutional Holdings
Institutions: 284
Institutional Holdings: 18.90M
% Owned: 90.07%
Shares Outstanding: 20.98M
TypeInstitutionsShares
Increased
70
1.16M
New
19
119.15K
Decreased
46
697.99K
Sold Out
25
492.35K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Drug Retailers
+1.23%
Food & Drug Retailing
+0.15%
Key Executives
Non-Executive Chairman/Independent Director
Gian Fulgoni
President/Chief Executive Officer/Director
Mathew Hulett
Chief Financial Officer/Treasurer/IR Contact Officer
Bruce Rosenbloom
Chief Technology Officer/Chief Information Officer
Mark Moseley
Chief Marketing Officer
Dan Pingree
Independent Director
Leslie Campbell
Independent Director
Ronald Korn
Independent Director
Diana Purcel
Independent Director
Jodi Watson
No Data
No Data
About PETS
PetMed Express, Inc. is a pet pharmacy. The Company markets prescription and non-prescription pet medications, health products and supplies for dogs, cats and horses, direct to the consumer. The Company’s product line contains approximately 3,000 stock-keeping units (SKUs). It also offers sale additional pet supplies on its Website, which are drop shipped to the customers by third parties. Its product line provides customers with a range of selections across the health categories for dogs, cats and horses. The Company’s current products include Non-Prescription Medications (OTC) and supplies and Prescription Medications (Rx). OTC includes flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes Heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Webull offers kinds of Petmed Express Inc stock information, including NASDAQ:PETS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PETS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PETS stock methods without spending real money on the virtual paper trading platform.